Kantar Health names Catherine Verneuil deputy head of oncology dept
This article was originally published in Scrip
Catherine Verneuil has joined Kantar Health, a healthcare-focused global consultancy and marketing insights company based in France, as deputy head of the oncology department. In the role, Ms Verneuil will focus on team management, restructuring and project profitability. She has 25 years' experience in market research, having most recently served as managing director of the market research company Audirep.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.